Differential integrin expression in thyroid and laryngeal carcinomas

Maria Teresa Carlevato, Livio Trusolino, Guido Serini, Guido Valente, Fabio Orlandi, Alberto Angeli, Giorgio Cortesina, Pier Carlo Marchisio

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Several laryngeal and thyroid carcinomas were studied immunohistochemically to evaluate whether the expression and distribution of integrins and basal lamina components can represent reproducible markers for correct diagnosis and prognosis. In laryngeal cancers, the depolarization and pericellular redistribution of α3β1 and α6β4, and focal or fragmentation of the basal lamina, according to tumor prognosis, occurred. In thyroid carcinomas, loss of polar topography of α3β1 and neo-expression of α6β4 in histopathologically or clinically aggressive cancers were observed. Therefore, the addition of a panel of adhesion molecules to the toolbox of surgical pathologists may improve diagnostic and prognostic procedures.

Original languageEnglish
Pages (from-to)2379-2384
Number of pages6
JournalAnticancer Research
Volume16
Issue number4 C
Publication statusPublished - Jul 1996

Fingerprint

Thyroid Neoplasms
Basement Membrane
Integrins
Laryngeal Neoplasms
Neoplasms
Pathologists

Keywords

  • Adhesion molecules
  • Integrins
  • Laryngeal cancer
  • Thyroid cancer

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Carlevato, M. T., Trusolino, L., Serini, G., Valente, G., Orlandi, F., Angeli, A., ... Marchisio, P. C. (1996). Differential integrin expression in thyroid and laryngeal carcinomas. Anticancer Research, 16(4 C), 2379-2384.

Differential integrin expression in thyroid and laryngeal carcinomas. / Carlevato, Maria Teresa; Trusolino, Livio; Serini, Guido; Valente, Guido; Orlandi, Fabio; Angeli, Alberto; Cortesina, Giorgio; Marchisio, Pier Carlo.

In: Anticancer Research, Vol. 16, No. 4 C, 07.1996, p. 2379-2384.

Research output: Contribution to journalArticle

Carlevato, MT, Trusolino, L, Serini, G, Valente, G, Orlandi, F, Angeli, A, Cortesina, G & Marchisio, PC 1996, 'Differential integrin expression in thyroid and laryngeal carcinomas', Anticancer Research, vol. 16, no. 4 C, pp. 2379-2384.
Carlevato MT, Trusolino L, Serini G, Valente G, Orlandi F, Angeli A et al. Differential integrin expression in thyroid and laryngeal carcinomas. Anticancer Research. 1996 Jul;16(4 C):2379-2384.
Carlevato, Maria Teresa ; Trusolino, Livio ; Serini, Guido ; Valente, Guido ; Orlandi, Fabio ; Angeli, Alberto ; Cortesina, Giorgio ; Marchisio, Pier Carlo. / Differential integrin expression in thyroid and laryngeal carcinomas. In: Anticancer Research. 1996 ; Vol. 16, No. 4 C. pp. 2379-2384.
@article{9e1898eacfe34e7387a627b74924f095,
title = "Differential integrin expression in thyroid and laryngeal carcinomas",
abstract = "Several laryngeal and thyroid carcinomas were studied immunohistochemically to evaluate whether the expression and distribution of integrins and basal lamina components can represent reproducible markers for correct diagnosis and prognosis. In laryngeal cancers, the depolarization and pericellular redistribution of α3β1 and α6β4, and focal or fragmentation of the basal lamina, according to tumor prognosis, occurred. In thyroid carcinomas, loss of polar topography of α3β1 and neo-expression of α6β4 in histopathologically or clinically aggressive cancers were observed. Therefore, the addition of a panel of adhesion molecules to the toolbox of surgical pathologists may improve diagnostic and prognostic procedures.",
keywords = "Adhesion molecules, Integrins, Laryngeal cancer, Thyroid cancer",
author = "Carlevato, {Maria Teresa} and Livio Trusolino and Guido Serini and Guido Valente and Fabio Orlandi and Alberto Angeli and Giorgio Cortesina and Marchisio, {Pier Carlo}",
year = "1996",
month = "7",
language = "English",
volume = "16",
pages = "2379--2384",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "4 C",

}

TY - JOUR

T1 - Differential integrin expression in thyroid and laryngeal carcinomas

AU - Carlevato, Maria Teresa

AU - Trusolino, Livio

AU - Serini, Guido

AU - Valente, Guido

AU - Orlandi, Fabio

AU - Angeli, Alberto

AU - Cortesina, Giorgio

AU - Marchisio, Pier Carlo

PY - 1996/7

Y1 - 1996/7

N2 - Several laryngeal and thyroid carcinomas were studied immunohistochemically to evaluate whether the expression and distribution of integrins and basal lamina components can represent reproducible markers for correct diagnosis and prognosis. In laryngeal cancers, the depolarization and pericellular redistribution of α3β1 and α6β4, and focal or fragmentation of the basal lamina, according to tumor prognosis, occurred. In thyroid carcinomas, loss of polar topography of α3β1 and neo-expression of α6β4 in histopathologically or clinically aggressive cancers were observed. Therefore, the addition of a panel of adhesion molecules to the toolbox of surgical pathologists may improve diagnostic and prognostic procedures.

AB - Several laryngeal and thyroid carcinomas were studied immunohistochemically to evaluate whether the expression and distribution of integrins and basal lamina components can represent reproducible markers for correct diagnosis and prognosis. In laryngeal cancers, the depolarization and pericellular redistribution of α3β1 and α6β4, and focal or fragmentation of the basal lamina, according to tumor prognosis, occurred. In thyroid carcinomas, loss of polar topography of α3β1 and neo-expression of α6β4 in histopathologically or clinically aggressive cancers were observed. Therefore, the addition of a panel of adhesion molecules to the toolbox of surgical pathologists may improve diagnostic and prognostic procedures.

KW - Adhesion molecules

KW - Integrins

KW - Laryngeal cancer

KW - Thyroid cancer

UR - http://www.scopus.com/inward/record.url?scp=0029789487&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029789487&partnerID=8YFLogxK

M3 - Article

VL - 16

SP - 2379

EP - 2384

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 4 C

ER -